Not Signed In - GlaxoSmithKline Acquires Exclusive Rights To Over-the-counter Orlistat For Markets Outside The US From Roche Group
Sun, 25 Feb 2007 08:00 AM EST
... GlaxoSmithKline plc (GSK) announced today that it has acquired from Roche Group exclusive rights to the weight-loss medicine, orlistat, for over-the-counter (OTC) use in markets outside the US, excluding Japan. GSK anticipates filing orlistat for OTC approval in Europe and certain key international markets by the end of 2007. [click link for full article] ...
Related Topics
- Orlistat
- Over-the-Counter Medicines
- Support Groups
- Personal Medical Records
- Psychotherapy
- Reproductive Rights
- Oseltamivir
- Group A Streptococcal Infection
- Advocacy
- ABO Blood Groups
- Group B Streptococcal Infection
- Social Support
- Bereavement
- TBI
- Group modalities
- Group B streptococcal septicemia of the newborn
- Dissociative Disorders
- Alopecia Areata
- Ketoconazole Topical
- Streptococcal Infections
email this page
print this page
bookmark this page
feedback on this page
